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Abstract: Disruption of epigenetic regulation by environmental toxins is an emerging area of
focus for understanding the latter’s impact on human health. Polybrominated diphenyl ethers
(PBDEs), one such group of toxins, are an environmentally pervasive class of brominated flame
retardants that have been extensively used as coatings on a wide range of consumer products.
Their environmental stability, propensity for bioaccumulation, and known links to adverse health
effects have evoked extensive research to characterize underlying biological mechanisms of toxicity.
Of particular concern is the growing body of evidence correlating human exposure levels to behavioral
deficits related to neurodevelopmental disorders. The developing nervous system is particularly
sensitive to influence by environmental signals, including dysregulation by toxins. Several major
modes of actions have been identified, but a clear understanding of how observed effects relate to
negative impacts on human health has not been established. Here, we review the current body of
evidence for PBDE-induced epigenetic disruptions, including DNA methylation, chromatin dynamics,
and non-coding RNA expression while discussing the potential relationship between PBDEs and
neurodevelopmental disorders.
Keywords: polybrominated diphenyl ethers (PBDE); neurodevelopment; epigenetics; DNA methylation;
chromatin remodeling; environmental toxins; toxicity
1. Introduction
Across the world, humans face exposure to a vast number of industrial chemicals, whose potential
for negatively impacting human health has long been a concern [1–3]. In early 2018, the United States
Environmental Protection Agency (EPA) reported 30,972 active chemicals in industry out of a total of
86,071 registered in the agency’s Toxic Substances Control Act (TSCA) Chemical Substance Inventory.
The European Chemicals Agency’s (ECHA) most recently updated figure from their relatively new
Regulation for Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) initiative
reports 21,403 unique substances. China has also established a program recently—similar to Europe’s
REACH regulations—that mandates new updating of China’s chemical inventory, the Inventory of
Existing Chemical Substances (IECSC), which lists 45,612 substances as of 2013. As world governments
attempt to define what chemicals have been produced and are in use, efficient methods to identify
and evaluate compounds for safety screening are still being debated and formed. Progress is slow,
with few chemicals actually being heavily regulated. In the US, the history of chemical regulation
is long and convoluted, and is well reviewed elsewhere [4]. Presently, the EPA is in the midst of a
three-tiered evaluation program designed to assess the safety of existing chemicals, with only the most
dangerous chemicals likely to ever reach the eventual ‘Risk Management’ phase. It is questionable
whether this type of approach is practical at all, yet meaningful change may not come soon, as it is
unlikely that the country will shift the burden of proof regarding chemical safety from regulatory
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agencies to manufacturers (as with Europe’s REACH program). In the meantime, the vast volume
and diversity of industrial chemicals we expose ourselves to continues to pose a potentially serious
risk to human health. There are numerous avenues by which hazardous compounds may impact
human health, perhaps the most widely recognized of which are potential for carcinogenicity, adverse
effects on reproductive health, and disruption of hormonal signaling. Another exceedingly concerning
endpoint for human health is nervous system toxicity, particularly during development of the brain.
The developing brain is an especially vulnerable target due to the complex nature of its formation and
refinement that spans prenatal and years of postnatal development. As such, neurodevelopmental
toxicity induced by chemical exposures has been heavily studied [5], but much remains unclear. Here,
we will focus on a class of industrial chemicals that has been under heavy scrutiny for suspected
neurodevelopmental toxicity: polybrominated diphenyl ethers (PBDEs).
PBDEs are a group of environmentally persistent chemicals that have been widely used as flame
retardants on household consumer products since 1970s. Due to their environmental stability and
propensity for bioaccumulation, PBDE concentrations have ubiquitously and cumulatively built up in
our environment and in our bodies around the globe. Intriguingly, PBDEs enter the environment from
both anthropogenic and natural sources. Historically, these compounds were first described in the
biomedical literature as early as the 1960s—a decade before their anthropogenic production—when
they were isolated from Australian marine sponges (Dysidea sp.) and found to have antimicrobial
properties [6–8]. They have also been isolated from various red algae [9,10]. Recently, in the case of
sponges, it was demonstrated that PBDEs are actually produced by symbiotic cyanobacteria and are
theorized to confer some level of microbial resistance to the host sponges, although the mechanism(s)
by which the compounds are toxic to other organisms remains unknown [11]. It is interesting to note,
however, that these compounds are excreted by the cyanobacteria and subsequently accumulate in
high concentrations, crystalizing in the sponge ectosomal tissues. This is perhaps how sponges avoid
the compounds’ toxic effects and how they may be a defense mechanism against potential eukaryotic
predators such as fish in addition to other prokaryotes [12]. In the context of human health, it is
unfortunate that such a class of compounds, whose natural production was likely evolutionarily driven
by their toxicity, ended up becoming a flame retardant of choice for consumer products. Understanding
the natural origins of PBDEs may also inform our investigation of their biological effects in humans,
which is of pressing importance given another unfortunate aspect of PBDE biology—the growing
evidence for their epidemiological association with neurodevelopmental disorders (NDDs). In this
review, we will briefly discuss known biological mechanisms affected by PBDEs, focusing on epigenetic
impairments and the impacts these disruptions may have on human health, especially in the context of
neurodevelopmental disorders.
2. Methods
Records were initially identified by searching PubMed and Web of Science databases for
combinations of the terms: ‘PBDE’, ‘BDE’, ‘polybrominated diphenyl ethers’, ‘chromatin’, ‘methylation’,
‘DNA methylation’, ‘histone’, ‘histone modification’, and ‘non-coding RNA’. In total, 122 records
were identified from the searches. We found 38 unique records after removal of duplicates and full
text screening for studies that specifically reported epigenetic endpoints (chromatin integrity, DNA
methylation, histone expression/histone modifications, non-coding RNA expression). All included
studies were used for qualitative analysis. No quantitative meta-analysis was conducted. Figure 1 was
created with BioRender.
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Figure 1. Polybrominated diphenyl ethers (PBDE) exposures affect epigenetic regulatory mechanisms 
at multiple levels, across multiple biological systems. There are several major aspects of human health 
that are of concern regarding PBDE toxicity that now have evidence for an involvement of 
dysregulated epigenetic regulation. These include: nervous system toxicity, disruption of thyroid 
hormone signaling, effects on the reproductive system (primarily on the placenta and testes), and 
oncogenic potential. One or more epigenetic components are known to be disrupted in each of these 
systems. In this review, we discuss these epigenetic regulators, their known modes of disruption by 
PBDEs, and the relationship of these disruptions to human health. 
3. Relation of PBDEs to Human Health 
3.1. Human Exposure to PBDEs and Effects on Human Health, Especially Neurodevelopmental Disorders 
A major effort has been devoted to evaluating the potential risk of PBDE exposure to human 
health. For the sake of brevity, here, we will highlight some of the major points while pointing to 
relevant reviews and meta-analyses of the vast number of studies that have been published on the 
topic. Monitoring of environmental and human levels of PBDEs in the 1990s led to a rising general 
concern that they may be a serious human health risk, which was widely recognized by the early 
2000s [13]. At the time, the extents of compounds’ toxicity were unclear despite the observed 
increasing toxicological evidence. Following much attention in the time since, it is now clear that 
exposure to PBDEs is a very real concern for humans around the world as the compounds are 
environmentally stable and lipophilic, and thus tend to bioaccumulate and also collect in households, 
primarily in dust. These routes of accumulation enable the most common modes of human 
exposure—primarily through ingestion and inhalation of dust [14,15] and dietary intake, 
predominantly from seafood and dairy products [16]. It is also concerning and of interest that infants 
and toddlers tend to have higher body burdens compared to adults when considering potential 
developmental toxicity [17]. This is thought to be caused by younger children having higher rates of 
intake from dust and household products, as well as by additional exposure to PBDEs through 
breastmilk.  
Figure 1. Polybrominated diphenyl ethers (PBDE) exposures affect epigenetic regulatory mechanisms
at multiple levels, across multiple biological systems. There are several major aspects of human health
that are of concern regarding PBDE toxicity that now have evidence for an involvement of dysregulated
epigenetic regulation. These include: nervous system toxicity, disruption of thyroid hormone signaling,
effects on the reproductive system (primarily on the placenta and testes), and oncogenic potential. One
or more epigenetic components are known to be disrupted in each of these systems. In this review, we
discuss these epigenetic regulators, their known modes of disruption by PBDEs, and the relationship of
these disruptions to human health.
3. Relation of PBDEs to Human Health
3.1. Human Exposure to PBDEs and Effects on Human Health, Especially Neurodevelopmental Disorders
A major effort has been devoted to evaluating the potential risk of PBDE exposure to human
health. For the sake of revity, her , we wil highlig t some of the major points while pointing to
r levant reviews and meta-analyses of the vast number f studies that have been published o the
topic. Monitoring of environmental and human levels of PBDEs in the 1990s l d to a rising ge eral
c n ern that they may be a serious human health ri k, which was widely recognized by the ea ly
2000s [13]. At the ti e, th ext nts of compounds’ oxicity ere unclear despite the observed increasing
toxicological evidence. Following much attention in the t me since, it is now cl ar hat expo u e to
PBDE is a very real oncern for humans around the world as the compou ds are environmentally
stable and lipophilic, and thus tend to bioaccumulate a d als collect in h useholds, pri arily in dust.
These routes of accumul tion enable the most common modes of human expo ure—primarily thr ugh
ingestion a d inhalation of d st [14,15] and dietary int ke, pr dominantly fr m seafood and dairy
products [16]. It is also concerning and f interest t t infants an toddlers tend to hav higher body
bur ens compared to adults when considering potential developm ntal toxicity [17]. This is thought
to be caus d by younger children having higher rates of intake from dust and household products, s
well as by additi nal exposure to PBDEs t rough breastmilk.
Int. J. Environ. Res. Public Health 2019, 16, 2703 4 of 13
Due to the persistent, widespread, and sometimes heavy exposure levels observed, much attention
has been given to the roles of PBDEs in several major aspects of health: carcinogenicity, reproductive
health, and disruption of hormonal signaling [16,18,19]. In addition to these concerning PBDE-related
effects on human health, another serious worry is their neurotoxicity and potential roles in the etiology
of neurodevelopmental disorders. A substantial amount of work has been done, surveying the
potential association of PBDE exposures with behavioral deficits in humans, as well as in other animal
models. Recently, several large-scale and systematic reviews have been conducted, both of evidence
from human [20–22] and animal studies [23]. Briefly, they conclude that PBDE exposures highly
correlate with externalizing behaviors and IQ in children, while BDE-47/99/209 were concluded to
affect learning in animal studies. There is also of concern for the relationship between environmental
toxins such as PBDEs and autism spectrum disorders, although the relationship is less clear, especially
in human studies [24]. Given the established and suspected connections between PBDE exposures and
intelligence and behavioral deficits, as well as other aspects of human health, it is imperative to strive
for a mechanistic understanding of PBDE toxicity at the molecular and cellular level (Figure 1).
3.2. Biological Mechanisms of PBDE Toxicity
Since the rise of concern regarding PBDE toxicity, several major impacted biological mechanisms
have been identified and investigated. These and other less explored effects of PBDEs have been recently
reviewed [25]. Briefly, major identified points of toxicity are: (1) disruption of calcium signaling—dating
back to one of the earliest functional studies of PBDEs [26]; (2) interference with thyroid hormone
homeostasis—thought to be enabled by structural similarity to the hormones; (3) general cellular
toxicity driven by mitochondrial disruption and elevated production of reactive oxygen species (ROS),
in some cases leading to DNA damage and apoptosis. However, some of the specifics of these known
effects remain unresolved and other unknown mechanisms may be involved. Additionally, most
studies have focused on individual PBDEs, while there are 209 congeners that humans are exposed
to in mixtures, and these compounds can be further processed to produce various metabolites. Such
metabolism, thought to be endogenously mediated in humans by cytochrome P450 enzymes [27–29]
and inherent in some other natural contexts [9–11,30], leads to the production of hydroxylated and
methoxylated forms that await in-depth investigation. Additional confounding factors include that
past studies have covered a wide range of concentrations, many likely higher than environmentally
relevant exposures, and much of this work has been conducted in cell culture, requiring further in vivo
confirmation. Thus, while an extensive amount of work has been done, there is much that may yet be
uncovered regarding biological mechanisms of PBDE toxicity.
A recently expanding approach towards understanding PBDE toxicity has focused on
PBDE-induced disruption of epigenetic regulation. Such mechanisms are interesting as potential
PBDE targets as they would constitute a direct gene-environment platform for cellular disruption.
Further, there is an expanding appreciation for the role of epigenetic mechanisms in neurodevelopment
and cognition [31,32], as well as in diseases of the nervous system, including neurodevelopmental
disorders [33,34]. Therefore, it may prove useful to understand the effects of PBDE exposures on
epigenetic components, both in the brain and across other cell and tissue types, in order to build
more complete causal models towards explaining observed links to human health complications
and behavioral deficits. However, compared to other widely studied mechanisms, relatively little
attention has been given to epigenetic effects of PBDEs. Here, we will summarize the findings of studies
conducted to date that have observed epigenetic endpoints such as DNA methylation, chromatin
characteristics including modifications and remodeling of histones, and other epigenetic mechanisms
such as expression of various non-coding RNAs.
3.3. Repeatedly Observed Disruption of DNA Methylation
One of the most commonly recognized epigenetic mechanisms is DNA methylation. Methylation
commonly occurs at cytosine nucleotides positioned before a guanosine (CpG dinucleotides), resulting
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in a 5-methylcytosine. Given the extensive impact methylation has on transcriptional regulation [35], it
comes as little surprise that its disruption has potential impacts on human health [36]. An interesting
example is folate deficiency’s implication in disrupted methylation during pre-natal development,
although the relationship is incompletely understood [37]. The relationship between PBDE exposure
and DNA methylation is similarly incompletely understood. Although most studies report some
correlation, they do not have a clear consensus, especially in human samples, while in vitro studies
more consistently report negative correlations (see references below).
Studies have assessed PBDE-exposure-dependent changes in global DNA methylation at various
representative regions or at specific loci (promoters). Two of the most prominent examples of
representative methylated regions include ALU elements and LINE1, which are common transposable
repeats that can have adverse cellular impacts when de-repressed due to hypomethylation [38].
Repetitive elements make up a large portion of the human genome [39] and have high CpG frequency,
contributing heavily to the global amount of DNA methylation and thereby serving as a reasonable
global estimate.
One of the earliest studies on the effects of PBDE exposure on global DNA methylation in humans
found a negative relationship between measured BDE-47 levels and ALU %5mC in blood samples of
healthy Korean adults, while not finding significant relationships for BDE-99 or LINE1 methylation [40].
Similar studies correlating PBDE levels in blood with methylation have followed. One found an inverse
relationship between BDE-47 abundance and TNFα promoter methylation in cord blood samples
from mother–infant pairs of the Boston Birth Cohort [41]. Another reports a more complex finding
in newborn cord blood samples from the CHAMACOS study, wherein significant changes in LINE1
methylation were found when considering co-exposure to DDT, DDE, and PBDEs (the direction of
change depended on level of DDE or DDT co-exposure) [42].
Several groups have also examined the relationship between PBDE levels and effects on the
placental epigenome. In 2016, two reports were published on effects in human placental samples. In one,
the authors made PBDE, PCB, DDE measurements in villous placental tissue samples and found positive
associations of PBDE levels with IGF2/H19 imprinting and methylation status (bisulfite conversion
and targeted pyrosequencing) and global DNA methylation (assessed by LUMA (luminometric
methylation assay)) [43]. In the other, PBDE levels in umbilical cord blood were measured from
eighty human samples and correlated with placental DNA methylation levels in LINE1, NR3C1, and
IGF2. BDE-66/153/209 were all found to have significant negative correlations with methylation of
some of these loci [44]. Two very recent reports have also been made utilizing in vitro models of the
placenta. One group exposed primary villous cytotrophoblasts (CTBs, an in vitro model of human
placental development) to BDE-47 or BDE-99. They found that BDE-47 alters gene expression in
a concentration-dependent manner and produced a low-level global increase in DNA methylation
(assessed with HumanMethylation450 beadarray) [45]. Another group exposed human placental
choriocarcinoma cells (BeWo cells) to 1 uM BDE-47 and found reduced methylation of some CpG loci
of mitochondrial biomarkers (with no differences found for 50 uM exposures) [46].
In addition to these human studies, PBDE-methylation relationships have also been investigated
in model animals—mostly rodents—both in vitro and in vivo. In vitro studies have been conducted
in different cell types, but consistently found negative correlations between PBDE exposure and
methylation level. In the earliest of these studies, primary hippocampal neurons were exposed
to various concentrations of BDE-209 for 24 hours and subsequently, a global decrease in DNA
methylation was found by an antibody based ‘ELISA-like’ assay [47]. Another found decreased global
DNA methylation after a 10 uM BDE-47 in murine N2A cells (assessed by HPLC and arbitrary primed
PCR). This decrease coincided with increased adipocyte differentiation (2.5–25 uM exposures) [48].
In a related effort to understand how endocrine-disrupting chemicals may be inducing adipocyte
differentiation, investigators report that BDE-47 induces demethylation of several sites in the PPARγ
promoter (a key adipongenic transcription factor) in COS7 and 3T3-L1 cells using Methylation-Sensitive
High-Resolution Melting (MS-HRM) [49]. Complementing these in vitro findings, in vivo studies that
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perinatally exposed rodents to BDE-47 reported interesting findings from offspring of various ages.
These include decreased expression of LINE1 RNA [50], decreased methylation of Mt-co2, L1Rn, Bdnf,
and Nr3c1 [51], differentially methylated regions in sperm [52], and global DNA hypomethylation
associated with behavioral deficits in both exposed wild-type and MeCP2-deficient female mice [53].
Another study in mice assessing liver carcinoma tissue after DE-71 (a commercial mixture of PBDEs)
exposure found little effect on global DNA methylation but reports a gene body methylation decrease
in Tbx3 and subsequent mRNA and protein upregulation [54]. While not directly assessing DNA
methylation, a multigenerational study in zebrafish that exposed F0 animals to a PCB and PBDE
mixture found disrupted behavior (hyper/hypoactivity) in F1–F4 larvae, as well as altered c-Fos
expression (F1/2) and altered Dmnt3ba expression in all generations [55].
To our knowledge, only two reports exist that found no relationship between PBDE exposure and
DNA methylation levels of any targets measured in those studies. One found no detectable decrease in
methylation at the p53 promoter after 24 hours of exposure to low micromolar doses (1, 5, 10 umol/L)
of BDE-47 in human neuroblastoma cells (SH-SY5Y), although activation of the p53 pathway in general
was implicated in observed effects [56]. The other found no significant relationship between BDE-47
serum levels and global methylation as assessed by the luminometric methylation assay (LUMA) in
samples from an elderly Swedish population. However, significant relationships were established
for other persistent organic pollutants including PCBs and the dioxin OCDD [57]. Aside from these
reports, the literature suggests a fairly consistent—but not necessarily linear—relationship between
PBDE exposures and DNA methylation levels. It is possible that changes may vary from genomic
region to region and may not always manifest an altered phenotype. Also, there is little evidence
concerning direct cause–effect relationships between methylation changes and behavioral phenotypes.
It will be both interesting and necessary to further refine understanding of the route by which PBDEs
affect DNA methylation states—be it primarily by dysregulation of DNA methyltransferase expression,
cellular metabolism, intracellular signaling pathways, etc.
3.4. Impact on Chromatin—Histone Modifications to Chromatin Remodeling
Other reversible chemical modifications of chromatin include modifications to histone proteins
that regulate chromatin structure and instruct remodeling processes, ultimately controlling gene
expression [58,59]. Studies starting as early as 2003 reported mixed results on PBDEs, inducing altered
chromatin by several measures (chromosomal integrity, chromatin density and localization). Exposure
of multiple bacterial strains to BDE-99 did not induce mutagenicity or a detectable increase in the
number of structural chromosomal aberrations, while exposure to the PCB mixture Aroclor®1254
did [60]. This early study explicitly stated that the possibility of PBDEs acting through epigenetic
mechanisms could not be ruled out, which, in retrospect, was prudent foresight. Two subsequent
studies have also reported no increase in degraded chromatin, both in sperm—the first in the sperm of
mice orally exposed to BDE-209 [61], the other in human samples of 153 men from the greater Montreal
area, despite establishing a correlation between BDE-47 levels and decreased sperm concentration [62].
However, there have also been a few studies that do report chromatin disruption following
PBDE exposure. One study found that 24 h nanomolar range exposures to several PBDEs
(BDE-47/99/153/183/209) induced micronuclei formation during cytokinesis in MCF-7 cells, an indicator
of chromosomal damage occurrence preceding cell division [63]. It has also been found that rat pups
exposed to a single injection of BDE-153 at post-natal day 10 (PND10) exhibited behavioral dysfunction
in a dose- and age-dependent manner one or two months later. Neurons in the CA3 region of the
hippocampus of these rats were also found to be undergoing significantly increased rates of apoptosis,
with chromatin condensed and localized to the nuclear membrane [64]. Most recently, it was reported
that BDE-209 exposures reduced hESC differentiation (although total induction was still greater than
90%) and also led to chromosomal copy number variants (CNVs), as well as decreased expression of
DNMT1/3A [65].
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There is also some evidence specifically for PBDE-induced dysregulation of histones and
histone-regulating proteins. In an effort to understand the carcinogenic potential of BDE-209, the
first such study found that HEK293T cells exposed to micromolar range levels of the toxin exhibited
altered expression of chromatin-regulating genes, specifically a histone gene cluster that the authors
hypothesize could affect nucleosome properties [66]. In the same year, another group reported
that exposure of the marine madaka (Oryzias melastigma) to BDE-47 led to sex-specific differential
protein expression in male and female gonads, with several histone variants (H2b, H3.3, H3a, H2a)
being down-regulated in male gonads [67]. Another study found that exposing maize (Zea mays L.)
to BDE-47, and its metabolites 6-OH-BDE-47 and 6-MeOH-BDE-47, led to elevated levels of ROS
and phospho-H2AX, likely in response to DNA damage. Interestingly, the hydroxylated metabolite
produced the most severe effects [68]. Another study, primarily concerned with the relationship of PBDE
exposure to reproductive health, exposed pregnant rats to BDE-47 from E8 to PND21. Male offspring
were then assessed at PND120 for alterations in testes. It was found that exposed rats had smaller testes,
decreased sperm production, and interestingly, an altered testes transcriptome and 4-fold decrease in
protamine and transition gene expression (proteins responsible for histone-protamine exchange) [69].
Aside from these data that indicate potential disruptions of histone expression and nucleosome
alteration, there are two studies that report PBDE-induced dysregulation of chromatin-regulating
proteins. The first found that BDE-47 treatment downregulated SirT1 expression (a histone deacetylase)
in the livers of mice due to NAD(+)-depletion [70]. Recently, we reported that chronic nanomolar range
doses of a hydroxylated metabolite of BDE-47, 6-OH-BDE-47, altered NDD candidate gene expression,
including several epigenetic regulators, particularly multiple components of the Brg1-associated factors
(BAF) chromatin remodeling complex [71].
The potential importance of understanding the effects of PBDEs on chromatin dynamics cannot be
understated given the fundamental importance of chromatin properties for regulating gene expression
and thus cellular states. Going forward, it will be important for investigators to focus on identifying
additional effects on chromatin while distinguishing those that are direct from indirect, hopefully
allowing for elucidation of the underlying mechanism.
3.5. Other Affected Epigenetic Mechanisms (Non-Coding RNAs)
Non-coding RNAs—such as long non-coding RNA (lncRNA) and microRNA (miRNA)—can also
act as epigenetic regulators [72,73]. Various PBDE exposures have been reported to alter expression of
miRNAs, and one study described effects on expression of liver lncRNAs. The earliest study assessing
miRNA expression as an endpoint following PBDE exposure utilized placental samples collected
from the National Children’s Study. Among other associations established for PCB and heavy metal
exposures, the study reported a positive association between BDE-209 and miR-188-5p expression
and an inverse association for BDE-99 and let-7c [74]. Another group exposed hESCs in vitro to low
doses of BDE-209 (1, 10, 100 nM) for 4 days, inducing apoptosis and downregulating pluripotency
genes, particularly OCT4, in part by hypermethylation of the promoter and induction of miR-145/335
which repress OCT4. There was also generation of ROS and decreased superoxide dismutase (SOD2)
expression. ROS and OCT4 effects were partially rescued by treatment with the antioxidant NAC [75].
An even more recent study employing human cells found that, after stimulating THP-1 macrophages
with BDE-209 and LDL, there was dose-dependent repression of miRNA-21 which subsequently
de-repressed toll-like receptor 4 expression (TLR4), enhancing TLR4-dependent lipid uptake [76–78].
In addition to these examples in humans, two rodent studies concerning non-coding RNAs in
the liver have been published. The first found that BDE-47 exposure upregulates CYP3A1 in rat
liver and that this upregulation is mediated by BDE-47-induced repression of miRNA-23b, which
negatively regulates CYP3A1 mRNA via a 3’ UTR binding site [79]. The other study reported that
conventional and gut-microbiome-depleted mice exhibit dysregulated lncRNA expression in liver
tissue in response to both BDE-47 and BDE-99 exposure [80]. Interestingly, BDE-47 has also been
found to induce dysregulation of novel miRNAs in exposed zebrafish larvae. Of particular interest is
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miR-735, which may play essential roles in larval sensory development, explaining previously observed
BDE-47-induced disruption of zebrafish visual perception [81]. In the near future, a general model
of PBDE-induced miRNA dysregulation may hopefully be established given the multiple intriguing
examples already characterized.
4. Conclusions
Considering this growing body of work documenting epigenetic dysregulation induced by
PBDE exposure, there appear to be several central lines of evidence emerging from research done in
various health contexts, including: adipocyte differentiation and obesity, reproductive health—of both
sperm/testes and the placenta, carcinogenicity (especially thyroid related), and negative impacts on
nervous system formation and function. It is becoming clear that many, if not all, of these various
aspects of human health are impacted by PBDE-induced disruption of normal epigenetic states
and mechanisms.
There are fairly consistent findings of a negative relationship between PBDE levels and DNA
methylation from in vitro and non-human animal studies across varied cell/tissue types and methylation
detection methods. However, the data from human samples is more difficult to interpret. Studies
reporting effects on global DNA methylation levels inferred from representative regions have
incongruent results, and evidence of alterations to methylation in the placenta are, likewise, not
in direct agreement. However, this confoundment and the fact that human studies have so far been
conducted across very different populations and models should only encourage further work on the
topic, especially given indications from non-human animal and in vitro studies. It will be of great
value if these types of studies can build on the tentatively established negative impact of PBDEs on
methylation and begin to focus on understanding the mechanisms underlying the alterations, while
continuing to clarify effects in human studies.
Compared to DNA methylation, the literature is poorer regarding the effects of PBDEs on other
epigenetic mechanisms such as chromatin dynamics and expression of non-coding RNAs. However,
some interesting ideas are beginning to emerge. While not yet well understood, PBDE-induced
dysregulation of histones and chromatin regulators is an intriguing intersection for PBDEs and
neurodevelopmental disorders, bolstered by the recent emergence of chromatin regulation as a major
node of NDD risk [31,82]. Further, it is tempting to speculate that epigenetic effects of PBDE exposure
may, generally, turn out to be a point of convergence for environmental and genetic factors that
contribute to NDDs. If the effects of these compounds on targets such as DNA methylation, chromatin
components and regulators, and non-coding RNA expression (all of which are mechanisms known to
have roles in neurodevelopment and perhaps NDD etiology) can be further explored and resolved,
one or more could very well turn out to be that link. This is of pressing importance, especially for
neurodevelopmental disorders considering their explosive increase in prevalence, growing evidence
for the involvement of PBDEs in their etiology, and the long elusive role of environmental factors in
these devastating conditions.
Going forward, a major challenge for epigenetic PBDE research will be to assimilate new findings
into the existing framework of PBDE toxicity that has been established from insights into other major
impacted biological mechanisms. It will also be important to carefully consider nuanced aspects of
exposures including tissue and sub-cellular localization, conduct more research on environmentally
relevant doses and mixtures of PBDEs, further explore the prevalence and effects of their metabolites,
and, to the extent that it is possible, integrate evidence generated across human and non-human studies
(both in vitro and in vivo). This will be necessary in order to construct a more wholistic understanding
of how these compounds impact cellular states and, ultimately, phenotypic outcomes. Hopefully, with
continued research, we may eventually be able to explain how and to what extent these pervasive
environmental pollutants are related to the numerous human health conditions that they appear to be
contributing to.
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